Serum levels of Fstl1 are elevated in human patients with pulmonary hypertension related to COPD, and in the lungs of hypoxic mice with high right ventricular systolic pressure (RVSP) and RVH (Zhang et al., 2017). Here, FSTL1 is linked to chronic obstructive pulmonary disease.